Home / Health / Mother's Plea: Son Will Die Without Accessible Medical Cannabis

Mother's Plea: Son Will Die Without Accessible Medical Cannabis

Summary

  • A 17-year-old faces imminent death due to inaccessible epilepsy medicine.
  • The Dutch pharmacy supplying critical medication is closing on December 1st.
  • Families are urging UK government intervention to secure vital supplies.

A critical shortage of epilepsy medication is threatening the life of a 17-year-old named Ben, whose mother is making an urgent plea for government intervention. Ben has severe drug-resistant epilepsy and relies on medicinal cannabis oils, Bedrolite and Bedica, prescribed for the last seven years. The Dutch pharmacy, Bedrocan, that supplies these medications has declared bankruptcy and is scheduled to close on December 1st, leaving Ben with only an estimated five weeks of supply.

Joanne, Ben's mother, expressed her profound fear, stating her son "will die" without the medication. She highlighted that after a previous interruption in treatment, Ben experienced 194 seizures in 18 hours, contrasting sharply with the over 90% reduction in seizures his family has reported since starting the cannabis oil. Ben's neurologist has recommended no change to his current treatment.

Campaigners are calling for immediate action from the UK government, urging intervention with Dutch ministers to secure the original plant material needed for UK production. They also seek emergency legislation to permit continued supply during Bedrocan's restructuring. Joanne has criticized the UK government's lack of response compared to initial communication from the Dutch government, which indicated a potential meeting to discuss temporary export of the necessary oils.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

Read more news on

Property Code: 5571